Cargando…
Prospects for Epigenetic Targeted Therapies of Bone and Soft-Tissue Sarcomas
Targeted therapies have revolutionized cancer treatment. It is well established that alterations of chromatin configuration and modifications affect tumorigenesis of some, possibly most, bone and soft-tissue sarcomas. As epigenetic regulators play a major role in the development of bone and soft-tis...
Autores principales: | Wang, Jun, Elkrief, Arielle, Guo, Wei, Shukla, Neerav, Gounder, Mrinal, Ladanyi, Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8328687/ https://www.ncbi.nlm.nih.gov/pubmed/34349608 http://dx.doi.org/10.1155/2021/5575444 |
Ejemplares similares
-
Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets
por: Nacev, Benjamin A., et al.
Publicado: (2022) -
Current Molecular Targeted Therapies for Bone and Soft Tissue Sarcomas
por: Nakano, Kenji, et al.
Publicado: (2018) -
Prospective Clinical Genomic Profiling of Ewing Sarcoma: ERF and FGFR1 Mutations as Recurrent Secondary Alterations of Potential Biologic and Therapeutic Relevance
por: Ogura, Koichi, et al.
Publicado: (2022) -
Therapeutic Targets for Bone and Soft-Tissue Sarcomas
por: Miwa, Shinji, et al.
Publicado: (2019) -
Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma
por: Gounder, Mrinal M., et al.
Publicado: (2022)